News
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as ...
Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...
Markets are trying hard to see the bright side of bad news in the United States, anticipating dour data will trigger the ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
21h
MedPage Today on MSNDid FDA Pick the Wrong COVID Vaccine Strain Last Season?
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% ...
Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results